Clinical efficacy of Huangzhu Xinwei Decoction in the differentiation treatment of bile reflux gastritis of liver-stomach heat stagnation
-
摘要: 目的:探讨黄竹欣胃汤辨证治疗胆汁反流性胃炎(BRG)的临床效果。方法:随机将136例肝胃郁热型BRG患者分为对照组和观察组,每组68例,对照组给予常规西医治疗,观察组基于对照组治疗之上加予黄竹欣胃汤辅助治疗,评估2组治疗8周后的临床疗效,对比2组治疗前及治疗8周后的中医症状积分、胆汁反流情况(最长胆汁反流时间、胆汁反流次数、反流总时间占比)、血清胃泌素(GAS)及血浆胃动素(MTL)水平变化情况。结果:观察组的临床总有效率显著高于对照组(95.59%、85.29%,P<0.05);治疗8周后,2组胃脘疼痛、胃脘灼热、脘腹胀满、嗳气、胃中嘈杂、纳呆少食、烦躁易怒、体重减轻、便秘共9项中医症状积分及总积分较治疗前有显著降低(P<0.05),2组最长胆汁反流时间较治疗前有显著缩短(P<0.05),胆汁反流次数较治疗前有显著减少(P<0.05),反流总时间占比较治疗前有显著降低(P<0.05),2组血清GAS较治疗前有显著降低(P<0.05),血浆MTL水平较治疗前有显著性提升(P<0.05),观察组以上指标改善显著优于对照组(P<0.05)。结论:黄竹欣胃汤辅助西医治疗能提高肝胃郁热型BRG患者的临床疗效,可明显缓解中医症状,改善胆汁反流情况,并促进血清GAS及血浆MTL水平提高,以促进胃肠功能改善。Abstract: Objective: To investigate the clinical effect of Huangzhu Xinwei Decoction in the differentiation treatment of bile reflux gastritis(BRG).Methods: One hundred and thirty-six patients with BRG of liver-stomach stagnation-heat type were randomly divided into control group and observation group, with 68 cases in each group. The control group was treated with conventional western medicine, and the observation group was additionally treated with Huangzhu Xinwei Decoction based on the above. The clinical efficacy of the two groups was evaluated after 8 weeks of treatment, and the TCM symptoms scores, bile reflux status(the longest bile reflux time, frequency of bile reflux, the proportion of total reflux time) and levels of serum gastrin(GAS) and plasma motilin(MTL) were compared between the two groups before treatment and after 8 weeks of treatment.Results: The total clinical effective rate of observation group was significantly higher than that of control group(95.59%,85.29%, P<0.05). After 8 weeks of treatment, the scores of 9 items of TCM symptoms of stomach duct pain, gastric burning, abdominal fullness and distention, belching, noisy stomach, anorexia and poor appetite, anxiety and and irritability, weight loss and constipation and the total score in the two groups were significantly decreased compared with those before treatment(P<0.05), and the longest bile reflux time in the two groups was significantly shorter than that before treatment(P<0.05), and the frequency of bile reflux was significantly reduced compared to before treatment(P<0.05), and the proportion of total reflux time was significantly lower compared to before treatment(P<0.05), and the level of serum GAS in the two groups was significantly reduced compared with that before treatment(P<0.05) while the level of plasma MTL was significantly risen compared to before treatment(P<0.05), and the improvement status of the above indicators in observation group were significantly better than those in control group(P<0.05).Conclusion: Huangzhu Xinwei Decoction supplemented with western medicine can improve the clinical efficacy of patients with BRG of liver-stomach stagnation-heat type, can significantly relieve the TCM symptoms, improve bile reflux status, and promote the increases of serum GAS and plasma MTL to improve gastrointestinal function.
-
Key words:
- Huangzhu Xinwei Decoction /
- bile reflux gastritis /
- serum gastrin /
- plasma motilin
-
-
[1] 罗晔,张声生,吴茜,等.张声生教授从胆胃相关论治胆汁反流性胃炎的临证经验[J].中国中西医结合消化杂志,2020,28(12):970-973.
[2] 赵海燕,梁军,边巴多杰,等.高原地区胆汁反流性胃炎的临床特征及危险因素[J].西部医学,2021,33(3):406-410.
[3] 苏保伟,林强,王景杰.胆汁反流性胃炎与肠化生的关系及其分子机制[J].山西医科大学学报,2021,52(3):344-349.
[4] 魏晏,魏群,魏明,等.奥瑞凝胶对胆汁反流性胃炎患者胃肠激素与炎症反应的影响[J].中医学报,2018,33(10):2003-2007.
[5] 谢斌,谢蓉.自拟中药方治疗胆汁反流性胃炎40例临床分析[J].养生保健指南,2021,(18):115-116.
[6] 沈静,袁红霞.袁红霞教授诊治胆汁反流性胃炎经验探析[J].中国中西医结合消化杂志,2020,28(7):546-548.
[7] 景云玲,张茜.清热降逆方药加减治疗胆汁反流性胃炎效果观察[J].中华养生保健,2021,39(9):11-12.
[8] 彭勇,常智玲,张华,等.利胆祛湿汤加减治疗湿热中阻型胆汁反流性胃炎的临床观察[J].时珍国医国药,2019,30(2):412-414.
[9] 贝政平,蔡映云.内科疾病诊断标准[M].2版.北京:科学出版社,2007:226-228.
[10] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:15.
[11] 孙传兴.临床疾病诊断依据治愈好转标准[M].2版.北京:人民军医出版社,1998:71-77.
[12] 高境蔚,杨代兰,李罗红,等.硫糖铝混悬液联合奥美拉唑肠溶片治疗隆起糜烂性胃炎[J].西部医学,2020,32(7):990-993.
[13] 张爱华,杨琳娜.艾司奥美拉唑、多潘立酮联合铝碳酸镁治疗胆汁反流性胃炎[J].实用中西医结合临床,2021,21(11):74-75.
[14] 张辛,周红梅.多潘立酮与莫沙必利治疗胆汁反流性胃炎患者的效果比较[J].河南医学研究,2020,29(26):4924-4925.
[15] 李雪,王静,朱磊.奥美拉唑联合铝碳酸镁和莫沙必利治疗胆汁反流性胃炎的临床应用价值[J].当代医学,2020,26(7):31-33.
[16] 陈宇.熊去氧胆酸联合多潘立酮或莫沙必利治疗原发性胆汁反流性胃炎的疗效分析[J].实用临床医药杂志,2019,23(4):60-63.
[17] 陈龙.原发性胆汁反流性胃炎应用莫沙必利与多潘立酮的治疗效果研究[J].健康必读,2021,(1):93.
[18] 熊利红.自拟调脾养胃汤对胆汁反流性胃炎患者胃肠激素及血清炎症因子的影响[J].现代中西医结合杂志,2018,27(8):889-891.
[19] 李嘉宁,王帅,迟莉丽.迟莉丽教授基于“邪在胆,逆在胃”辨治胆汁反流性胃炎[J].吉林中医药,2020,40(10):1292-1295.
[20] 罗昭琼,朱永钦,朱永苹,等.胆汁反流性胃炎的病因和发病机制研究进展[J].广西中医药大学学报,2016,19(2):79-81.
[21] 夏秋钰,周静洁,陈正平,等.中西医结合治疗肝胃郁热型胃食管反流病50例临床研究[J].江苏中医药,2020,52(8):31-32.
[22] 赵悦,皮微平,戴颖慧,等.胃病证治探讨[J].空军医学杂志,2020,36(1):92-92.
[23] 陈庆利,徐艳,苏政振.自拟柴附顺气汤治疗胆汁反流性胃炎疗效及对中医症候、胃镜下胆汁反流程度和血清GAS水平的影响[J].四川中医,2019,37(12):90-92.
[24] 庞彩霞,冯健科.胆囊切除术后慢性胃炎伴胆汁反流患者血清胆囊收缩素,胃泌素,胃动素水平研究[J].解放军预防医学杂志,2019,37(10):34-35.
-
计量
- 文章访问数: 124
- PDF下载数: 55
- 施引文献: 0